Clinical Trials Directory

The PARTNER II Trial "Placement of AoRTic TraNscathetER" Valves Trial" (US) [Edwards Study 2010-12]

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT and the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Stanford is now accepting new patients for this trial.

Investigator(s):

Intervention(s):

  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis
  • device : TAVR Implantation of the Transcatheter Aortic Valve Prosthesis

Phase: Phase 3

Eligibility

Ages Eligible For Study:

N/A - N/A

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Martina Kelly Speight
6507252687
Recruiting

Footer Links: